NCT07842549Completed
Multicenter Study of Clinical-Pathological Correlation in cT2N0 Gastric Cancer and Its Prognostic Implications
Source: ClinicalTrials.gov · Last updated 25 Sept 2026
Brief summary (registry, in English)
In gastric cancer, accurate preoperative staging of patients with T2N0 disease remains challenging. Correct assessment of tumor depth and lymph node involvement is particularly important in this subgroup, as treatment strategies may differ depending on the final stage. This study aims to correlate preoperative diagnostic findings with postoperative histopathological results in patients with suspected T2N0 gastric cancer, in order to assess the accuracy of current staging modalities and identify factors that may improve preoperative staging and guide treatment selection.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 1024 (actual)
- First submitted
- 7 Sept 2026
- Start date
- 1 Jan 2014
- Primary completion date
- 8 Jul 2016
- Lead sponsor
- Hospital of Navarra
- NCT number
- NCT07842549
What you commit to
- Study type: Observational
- Participants enrolled: 1024
- From 1 Jan 2014 to the primary completion date, 8 Jul 2016
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- metastatic disease, non-curative resections.
Who the study is looking for
- gastric adenocarcinoma, cT2N0 classification (CT scan/echoendoscopy), surgery with or without neoadjuvant therapy, pTNM stage recorded.
Sex: Male · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hospital de Navarra Coordinator of this site? Confirm its status | Pamplona | Spain | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.